Skip to main content

Find Clinical Trials

Home
Conditions
Glioma

Clinical trial condition

Glioma

Explore clinical trials studying Glioma. Study availability and eligibility vary by location and protocol.

1,342 public trials 293 recruiting studies

Refine in advanced search Browse all conditions

Glioma trial results

Completed

VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide

NCT00369590

Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations: University of California Los Angeles Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

NCT01111097

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Completed

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

NCT00704808

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Not specified

View Trial Details

Completed

Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)

NCT00725010

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Not specified

View Trial Details

Completed

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

NCT01462695

Conditions: Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma, Childhood Cerebral Anaplastic Astrocytoma, +19 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

View all 96 locations

View Trial Details

Completed

Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)

NCT01295632

Conditions: Adnexal Diseases, Advanced Cancer, Astrocytoma, +26 more
Locations: Not specified

View Trial Details

Completed

Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma

NCT01102595

Conditions: Astrocytoma, Glioblastoma, Glioblastomas, +8 more
Locations: Grupo Español de Investigacion en Neurooncologia Madrid, Spain

View Trial Details

Completed

APG101 in Glioblastoma

NCT01071837

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Medizinische Universität Graz, Universitätsklinik für Neurologie Landeskrankenhaus Graz Graz, Austria

Universitätsklinik für Neurologie, Landeskrankenhaus Innsbruck Innsbruck, Austria

Landesnervenklinik Wagner-Jauregg, Innere Medizin mit Neuroonkologie Linz, Austria

Allgemeines Krankenhaus der Stadt Wien, Klinische Onkologie Vienna, Austria

View all 21 locations

View Trial Details

Completed

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

NCT00004146

Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Moffitt Cancer Center Tampa, Florida, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

NCT01598597

Conditions: Adenocarcinoma, Astrocytoma, Breast Cancer, +45 more
Locations: Many Locations, Alabama, United States

Many Locations, Alaska, United States

Many Locations, Arizona, United States

Many Locations, Arkansas, United States

View all 50 locations

View Trial Details